Arcus Biosciences
RCUS
RCUS
193 hedge funds and large institutions have $791M invested in Arcus Biosciences in 2024 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 62 increasing their positions, 64 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
+22
Holders Change %
+12.87%
% of All Funds
2.81%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
43
Increased
62
Reduced
64
Closed
20
Calls
$3.58M
Puts
$2.31M
Net Calls
+$1.27M
Net Calls Change
-$894K
Top Buyers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
$64.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$80.1M |
| 3 |
Goldman Sachs
New York
|
$9.7M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
$22.5M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
$3.85M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
$46.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$63.7M |
| 3 |
Morgan Stanley
New York
|
$6.79M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
$0 |
| 5 |
UBS AM
Chicago,
Illinois
|
$1.48M |
